To further explore the inhibition of NPs to AID, the AID deficiency (AIDKO) SU-DHL-4 DLBCL cells were generated by the CRISPR/Cas9 technique targeting the human AICDA gene, which encodes AID protein [24,25]. This evidence concerns the gene AICDA and diffuse large B-cell lymphoma.